Advanced Targeting with Chimeric Antigen Receptors

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

Scientists from the University of Bristol, CNRS and Imophoron Ltd worked with the computer technology giant Oracle to develop a new kind of vaccine that needs no refrigeration. They used synthetic biology, cryo-electron microscopy and high-performance cloud computing to produce a candidate vaccine against the mosquito-borne chikungunya virus. Their findings could revolutionise the way vaccines are designed, developed and stored.